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Recent studies have demonstrated a strong
relationship between aging-associated reduc-
tions in mitochondrial function, dysregulated
intracellular lipid metabolism, and insulin
resistance.Given the important role of the AMP-
activated protein kinase (AMPK) in the regula-
tion of fat oxidation andmitochondrial biogene-
sis, we examined AMPK activity in young and
old rats and found that acute stimulation of
AMPK-a2 activity by 5
0-aminoimidazole-4-car-
boxamide-1-b-D-ribofuranoside (AICAR) and
exercise was blunted in skeletal muscle of old
rats. Furthermore, mitochondrial biogenesis in
response to chronic activation of AMPK with
b-guanidinopropionic acid (b-GPA) feeding
was also diminished in old rats. These results
suggest that aging-associated reductions in
AMPKactivitymay be an important contributing
factor in the reducedmitochondrial function and
dysregulated intracellular lipid metabolism as-
sociated with aging.
INTRODUCTION
The AMP-activated protein kinase (AMPK) is emerging as
a chief regulator of whole-body energy balance (Bolster
et al., 2002; Holmes et al., 1999; Kahn et al., 2005; Kimura
et al., 2003; Krause et al., 2002; Terada et al., 2002;
Winder et al., 1997, 2000). In skeletal muscle, once AMPK
becomes activated, it exerts control in part by regulating
fatty-acid oxidation through the phosphorylation of ace-
tyl-CoA carboxylase 2 (ACC2) and mitochondrial biogen-
esis through increasing the expression of proteins vital
for proper mitochondrial function such as citrate synthase
and succinate dehydrogenase (Bergeron et al., 2001;Cell MMerrill et al., 1997; Winder et al., 1997, 2000; Zong et al.,
2002). Reductions in mitochondrial oxidative-phosphory-
lation activity, which contribute to dysregulated intracellu-
lar lipid metabolism, have recently been implicated in the
increased incidence of insulin resistance and type 2 dia-
betes that occurs with aging (Petersen et al., 2003). Given
the critical role that AMPK plays in the regulation of mito-
chondrial biogenesis and fatty-acid oxidation, we exam-
ined the effect of aging on the AMPK signaling pathway
and mitochondrial biogenesis during acute pharmacolog-





(AICAR) is an acute activator of AMPK, which is taken up
into cells and converted into 50-aminoimidazole-4-carbox-
amide-1-b-D-ribofuranoside monophosphate (ZMP),
which mimics the effects of AMP on AMPK (Corton
et al., 1995). When bound to AMPK, AMP or ZMP induces
a conformational change that makes AMPK a better sub-
strate for activation by the upstream kinase LKB1 (Hawley
et al., 2003). In vivo AICAR infusions in 3-month-old
(‘‘young’’) and 28-month-old (‘‘old’’) Fisher 344 male rats
increased AMPK-a2 activity by 44% in the extensor
digitalis longus (EDL) muscles of the young AICAR-treated
rats versus young saline-treated (control) rats (Figure 1A).
In contrast, AICAR infusions did not increase AMPK-a2
activity in the old rats, demonstrating reduced AMPK ac-
tivation with aging. Furthermore, AMPK phosphorylation
of one of its key substrates in skeletal muscle, ACC2, at
serine 79 (Ser79) was increased by 120% in the young
AICAR-treated rats, whereas there was no difference in
the old AICAR-treated rats (Figure 1B).
AMPK activity is regulated by the phosphorylation of
threonine 172 (Thr172) on the catalytic a subunit of the en-
zyme (Hawley et al., 1996), and studies in tissue-specificetabolism 5, 151–156, February 2007 ª2007 Elsevier Inc. 151
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Aging-Associated Reductions in AMPKFigure 1. The Effect of AICAR Infusions on AMPK and LKB1 in Young and Old Rats
(A) AMPK-a2 activity in the EDL muscle of young and old rats infused with either AICAR or saline (control). AMPK-a2 activity was increased by 44% in
the young AICAR-treated rats compared to the young saline-treated rats. In contrast, there was no difference between the old AICAR-treated and
saline-treated rats. (n = 7–10 in each group.) *p = 0.01. In this and all other figures, values are presented as means ± SEM.
(B) p-ACC (Ser79) in the EDL muscle of young and old rats infused with either AICAR or saline (control). AICAR infusion resulted in a 120% increase in
p-ACC (Ser79) in the young rats. In contrast, there was no effect of AICAR infusion on p-ACC (Ser79) in the old rats. (n = 4–6 in each group.) *p < 0.05.
(C) p-AMPK (Thr172) in the EDL muscle of young and old rats infused with either AICAR or saline (control). AICAR infusion resulted in a 162% increase
in p-AMPK (Thr172) in the young rats. In contrast, there was no effect of AICAR infusion on p-AMPK (Thr172) in the old rats. (n = 4–6 in each group.)
*p < 0.05.
(D) LKB1 protein expression in the EDL muscle of young and old rats infused with either AICAR or saline (control). LKB1 protein expression in EDL
muscle of young and old rats did not differ significantly during aging or in response to AICAR infusion. (n = 4 in each group.)
(E) LKB1 activity in the EDL muscle of young and old rats infused with either AICAR or saline (control). LKB1 activity in the EDL muscle of young and old
rats did not differ significantly during aging or in response to AICAR infusion. (n = 4 in each group.)mouse knockouts suggest that LKB1 is the major up-
stream kinase in skeletal muscle, at least for a2 (Sakamoto
et al., 2005). The reduced AICAR-stimulated AMPK-a2 ac-
tivity could be attributed to reduced phosphorylation since
Thr172 phosphorylation increased by 162% in the young
AICAR-treated rats and was unaltered in the old AICAR-
treated rats (Figure 1C). These aging-associated differ-
ences in AMPK-a2 activity and Thr172 phosphorylation152 Cell Metabolism 5, 151–156, February 2007 ª2007 Elsevierbetween AICAR-treated and saline-treated rats were in-
dependent of any changes in AMPK-a1 activity or in the
expression of the AMPK-a1 and a2 subunits (see Figure S1
in the Supplemental Data available with this article online).
They also were not associated with changes in the expres-
sion (Figure 1D) or activity of LKB1 (Figure 1E) or in the
phosphorylation of Ser491 on AMPK-a2 (data not shown),
which has been reported to antagonize phosphorylationInc.
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short polypeptides (Hawley et al., 2003), which have
recently been identified as splice variants (S.A.H. and
D.G.H., unpublished data). Although the two forms were
expressed in almost equal amounts in rat skeletal muscle
by western blotting, their expression was not different in
the old rats.
Exercise
Exercise or contraction rapidly depletes ATP, which leads
to the increase in the AMP:ATP ratio that is responsible for
causing AMPK activation (Sakamoto et al., 2005; Winder
and Hardie, 1996). Groups of young and old Fisher 344
male rats that had been exercise trained for 5 days com-
pleted a 5-day treadmill exercise regimen that resulted
in a 110% increase in AMPK-a2 activity in the young
rats. In contrast, the old rats displayed severely blunted
AMPK-a2 activity in response to exercise (Figure 2A). Ad-
ditionally, phosphorylation of Ser79 on ACC2 was blunted
in the old rats despite a 127% increase in the young rats
(Figure 2B). Lastly, Thr172 phosphorylation increased
55% in the young exercising rats and did not change
in the old exercising rats compared to their controls
(Figure 2C). These aging-associated differences in
AMPK-a2 activity and Thr172 phosphorylation between
exercising rats and sedentary rats were independent of
any changes in AMPK-a1 activity or in the expression of
the AMPK-a1 and a2 subunits (Figure S1).
b-GPA Feeding
Recent studies have demonstrated that AMPK serves an
important role in regulating mitochondrial biogenesis
during chronic energy deprivation and is associated with
increased mRNA expression of peroxisome proliferator-
activated receptor g coactivator 1a (Pgc-1a), the tran-
scriptional coactivator responsible for mitochondrial
biogenesis in skeletal muscle. To investigate how aging
impacts AMPK-stimulated mitochondrial biogenesis, we
chronically fed young and old rats a diet with 1% b-guani-
dinopropionic acid (b-GPA) for 8 weeks. Since b-GPA has
a lower KM for creatine kinase than creatine, its presence
results in lower intramyocellular concentrations of ATP
and phosphocreatine and thus chronically stimulates
AMPK activity. Accordingly, AMPK-a2 activity (Figure 3A)
increased 146% in the EDL muscles of the young rats
fed the b-GPA diet. A similar increase was detected in
AMPK-a2 activity in the soleus tissue, an oxidative fiber,
demonstrating the broad effect of b-GPA on AMPK-a2 ac-
tivity in young rats. Pgc-1a mRNA expression (Figure 3B)
also increased, by 86%, in the EDL muscles of the young
rats fed the b-GPA diet. These increases in the young rats
were associated with a 38% increase in mitochondrial
density as assessed by electron microscopy (Figure 3C),
a 289% increase in d-ALA synthase (d-Alas) mRNA ex-
pression (Figure 3D), and a 76% increase in cytochrome
c protein expression (Figure 3E). In contrast, we observed
no increases in AMPK-a2 activity, Pgc-1a mRNA expres-
sion, mitochondrial density, d-Alas mRNA expression, or
cytochrome c protein expression in the EDL muscles ofCell MFigure 2. The Effect of Exercise on AMPK in Young and Old
Rats
(A) AMPK-a2 activity in the EDL muscle of exercising or sedentary
young and old rats. AMPK-a2 activity was increased by 110% in the
young exercising rats compared to the young sedentary rats. In con-
trast, there was no difference between the old exercising rats and
old sedentary rats. (n = 8 in each group.) *p = 0.01.
(B) p-ACC (Ser79) in the EDL muscle of exercising or sedentary young
and old rats. Exercise resulted in a 127% increase in p-ACC (Ser79) in
the young rats. In contrast, there was no effect of exercise on p-ACC
(Ser79) in the old rats. (n = 4 in each group.) *p < 0.05.
(C) p-AMPK (Thr172) in the EDL muscle of exercising or sedentary
young and old rats. Exercise resulted in a 55% increase in p-AMPK
(Thr172) in the young rats. In contrast, there was no effect of exercise
on p-AMPK (Thr172) in the old rats. (n = 4 in each group.) *p < 0.05.etabolism 5, 151–156, February 2007 ª2007 Elsevier Inc. 153
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Aging-Associated Reductions in AMPKFigure 3. The Effect of b-GPA Feeding on AMPK and Mitochondrial Biogenesis in Young and Old Rats
(A) AMPK-a2 activity in the EDL muscle of young and old rats fed either a b-GPA-supplemented diet or a control diet. The b-GPA-supplemented diet
resulted in a 146% increase in AMPK-a2 activity in the young rats. In contrast, the b-GPA-supplemented diet had no effect on AMPK-a2 activity in the
old rats. (n = 3–4 in each group.) *p < 0.01.
(B) Pgc-1a mRNA expression in the EDL muscle of young and old rats fed either a b-GPA-supplemented diet or a control diet. Pgc-1a mRNA expres-
sion increased by 86% in the young b-GPA-fed rats. In contrast, there was no difference in Pgc-1a mRNA expression in the old rats. (n = 5–8 in each
group.) *p < 0.05.
(C) Percent increase in mitochondrial density in the EDL muscle of young and old rats fed a b-GPA-supplemented diet compared to control rats. Mi-
tochondrial density increased by 38% in the young b-GPA-fed rats. In contrast, the b-GPA-supplemented diet resulted in no difference in mitochon-
drial density in the old rats. (n = 4–5 in each group.) *p < 0.05.
(D) d-Alas mRNA expression in the EDL muscle of young and old rats fed either a b-GPA-supplemented diet or a control diet. d-Alas mRNA expression
increased by 289% in the young b-GPA-fed rats. In contrast, there was no difference in d-Alas mRNA expression in the old rats. (n = 3–8 in each
group.) *p = 0.05.
(E) Cytochrome c protein expression in the EDL muscle of young and old rats fed either a b-GPA-supplemented diet or a control diet. Cytochrome c
protein expression increased by 76% in the young b-GPA-fed rats. In contrast, there was no difference in cytochrome c protein expression in the old
rats. (n = 4–8 in each group.) *p < 0.05 .the old rats. These results suggest that aging-associated
reductions in AMPK-stimulated activity may be an impor-
tant contributing factor in the reduced mitochondrial
function and dysregulated intracellular lipid metabolism
associated with aging-induced insulin resistance and
type 2 diabetes.154 Cell Metabolism 5, 151–156, February 2007 ª2007 ElsevierEXPERIMENTAL PROCEDURES
In Vivo AICAR Infusions
We studied Fisher 344 male rats aged 3 months (young) and 28 months
(old) (National Institute on Aging). The rats were maintained on stan-
dard rat chow (Ralston Purina) and housed in an environmentally con-
trolled room with a 12/12 hr light/dark cycle. Body weight and foodInc.
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catheterized via the right jugular vein and allowed to recover (5–8
days) until they regained their preoperative weight. Weight-matched
young and old animals were infused with isotonic saline (control) or
the AMPK activator 50-aminoimidazole-4-carboxamide-1-b-D-ribofur-
anoside (AICAR) (bolus, 100 mg/kg; constant, 10 mg/kg/min; Toronto
Research Chemicals Inc.) for 60 min. During the AICAR experiments,
plasma glucose concentrations were maintained constant at basal
concentrations (100 mg/dl) using a variable infusion of 20% (w/v) dex-
trose solution in order to prevent hypoglycemia. Blood was sampled
at 0 min and every 15 min for glucose measurements. At the end of
the infusions, rats were anesthetized with intravenous pentobarbital
(50 mg/kg), and the skeletal muscle was rapidly excised and freeze
clamped in liquid nitrogen.
Exercise
We studied Fisher 344 male rats aged 3 months (young) and 28 months
(old). The rats were maintained on standard rat chow (Ralston Purina)
and housed in an environmentally controlled room with a 12/12 hr light/
dark cycle. Body weight and food consumption were measured every
2–3 days. The rats were introduced to the treadmill (Columbus Instru-
ments) with a 10 min run at 10 m/min once per day for 4 days. A per-
formance test to determine the maximum running capacity for each
rat was performed on the fifth day by running the rats for 10 min at
10 m/min and then increasing the speed 1 m/min every minute until ex-
haustion. The young rats’ maximum capacity was determined to be
38 m/min, and the old rats’ maximum capacity was 20 m/min. The
speed at which all of the rats reached exhaustion was noted, and the
rats were run at 85% of that speed for 5 more days after a 2 day break
for 30 min each day. Thus, the young rats were run at 32 m/min, and the
old rats were run at 17 m/min. On the fifth day, immediately after exer-
cise, the rats were anesthetized with isoflurane, and the skeletal mus-
cle was rapidly excised and freeze clamped in liquid nitrogen.
Throughout this experiment, control rats remained sedentary in their
cages.
b-GPA Feeding
We studied Fisher 344 male rats aged 3 months (young) and 28 months
(old). The rats were maintained on standard rat chow (Ralston Purina)
with or without 1% b-GPA and were housed in an environmentally con-
trolled room with a 12/12 hr light/dark cycle. Body weight and food
consumption were measured every 2–3 days. On the eighth week of
feeding, the rats were chronically catheterized via the right jugular
vein and allowed to recover (5–8 days) until they regained their preop-
erative weight. The rats were then anesthetized with intravenous pen-
tobarbital (50 mg/kg), and the skeletal muscle was rapidly excised and
freeze clamped in liquid nitrogen for analytical procedures. Other skel-
etal muscle was prepared separately for mitochondrial quantification
using electron microscopy.
Electron Microscopy
Individual skeletal muscle samples were prepared by immersion in
2.5% glutaraldehyde (Electron Microscopy Sciences) in 0.1 M cacody-
late buffer (pH 7.4) at 4C overnight. Skeletal muscles were then
washed three times in 0.1 M cacodylate buffer (pH 7.4) and postfixed
for 1 hr in 1% osmium tetroxide (EMbed-812 epoxy resin) in the same
buffer at room temperature. After three washes in water, the samples
were stained for 1 hr at room temperature in 2% uranyl acetate,
washed again in water, and dehydrated in a graded series of ethanol
dilutions (50%–100%). The samples were then embedded in EMbed.
Ultrathin (60 nm) sections were cut using a Reichert Ultracut ultrami-
crotome, collected on formvar- and carbon-coated grids, stained
with 2% uranyl acetate and lead citrate, and examined in a Philips
410 electron microscope. Only cross-sections of skeletal muscle
were examined for quantification of mitochondrial density. For each in-
dividual rat and skeletal muscle, six random pictures were taken at
a magnification of 7,1003 and printed at a final magnification of
18,2503. The volume density of mitochondria was estimated usingCell Mthe point-counting method. The average volume density was calcu-
lated for each individual rat and skeletal muscle and was used to cal-
culate the average volume density for each treatment.
AMPK Activity Assays
At the end of the experiments, the rats were anesthetized as described
above. The EDL muscles from the left and right legs were quickly
freeze clamped in situ. Skeletal muscle samples were kept in liquid ni-
trogen until analyzed. EDL was ground with a mortar and pestle and
mixed with 1 ml of lysis buffer (50 mM Tris-HCl buffer [pH 7.5 at
4C], 50 mM NaF, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA, 1 mM dithio-
threitol [DTT], 1 mM benzamidine, 1 mM phenylmethanesulfonyl fluo-
ride [PMSF], glycerol [10% v/v], Triton X-100 [1% v/v]). Homogenates
were spun at 20,8003 g for 10 min at 4C, and protein concentrations
were determined. AMPK-a1 and AMPK-a2 were immunoprecipitated
overnight from cell lysates containing 1 mg of protein using 1 ml of
either AMPK-a1 antibody or AMPK-a2 antibody (Santa Cruz Biotech-
nology). Skeletal muscle AMPK-a1 and AMPK-a2 activity were deter-
mined by following the incorporation of [32P]ATP into a synthetic
peptide containing the AMARA sequence on the following day.
LKB1 Activity Assays
EDL muscle samples were frozen in liquid nitrogen and later ground
with a mortar and pestle. For each sample, the ground paste was ex-
tracted in 1 ml of lysis buffer as described above. Homogenates were
spun at 12,900 rpm for 10 min at 4C, and protein concentration was
estimated. LKB1 was immunoprecipitated from lysates containing
3 mg of protein using the N-terminal antipeptide antibody (Boudeau
et al., 2003). LKB1 assays (1 mg of lysate per assay) were conducted
using purified GST-AMPK-a1 catalytic subunit as substrate in shaking
incubators as described previously for immunoprecipitate kinase as-
says of AMPK (Hardie et al., 2000).
Real-Time Quantitative PCR Analysis
Total RNA was isolated from the EDL muscle using the RNeasy Kit
(QIAGEN). cDNA was prepared from 2 mg of RNA using the Strata-
Script RT-PCR kit (Strategene) with random hexamer primers accord-
ing to the manufacturer’s instructions. The resulting cDNA was diluted,
and a 4 ng aliquot was used in a 40 ml PCR reaction using SYBR green
and selected primers. The primers for d-Alas were 50-TTTGTGGAC
GAGGTCCATGCAGTA-30 (forward) and 50-GCATTCAGCTGAC
GAATGTGGCTT-30 (reverse). The primers for cytochrome c were 50-
TCTTGACTTCCTGACCTTGGGCTT-30 (forward) and 50-ACTCCCGC
TTCTTGTAGCTTTCCA-30 (reverse). PCR reactions were run in
duplicate and quantitated with an ABI Prism 7700 Sequence Detection
System (Applied Biosystems). Cycle threshold values were normalized
to b-actin mRNA expression.
Western Blotting
For all western blots except for LKB1 expression, 30 mg of cell lysate
was diluted in LDS Laemmli sample buffer before SDS-PAGE. SDS
gel electrophoresis was performed using precast Bis-Tris 4%–12%
gradient polyacrylamide gels in the MOPS buffer system (Invitrogen).
After transfer to nitrocellulose membranes, membranes were incu-
bated in blocking buffer (5% milk) for 1 hr and immunoblotted with
anti-p-AMPK (Thr172) antibody (Cell Signaling), anti-p-ACC (Ser79)
antibody (Cell Signaling), anti-AMPK-a1 antibody (Cell Signaling),
anti-AMPK-a2 antibody (Cell Signaling), or cytochrome c antibody
(Santa Cruz Biotechnology) at 1:1000 dilution in 5% bovine serum al-
bumin. The membranes were washed three times for 15 min with
TBS (10 mM Tris-HCl [pH 7.4], 0.5 M NaCl) plus Tween 20 (0.2% v/v)
(TBST). The membranes were immersed in blocking buffer and a corre-
sponding IgG-conjugated secondary antibody and were shaken for
1 hr. The membranes were then washed three times for 5 min using
TBST. Proteins were then detected with enhanced chemilumines-
cence, and autoradiographs were quantified using densitometry. For
western blotting of LKB1, 15 mg of tissue extract was diluted in LDS
sample buffer (Invitrogen). SDS gel electrophoresis was performedetabolism 5, 151–156, February 2007 ª2007 Elsevier Inc. 155
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MOPS buffer system (Invitrogen). Proteins were transferred to nitrocel-
lulose membranes (Bio-Rad) using the Xcell II Blot Module (Invitrogen).
Membranes were incubated in Odyssey blocking buffer (Li-Cor) for
1 hr. The membrane was subsequently incubated with 1:1000 anti-
LKB1 N-terminal antibody (raised against residues 24–36), which
had been diluted in Odyssey blocking buffer containing 0.2% Tween
20. The membranes were washed six times for 5 min with TBST. The
membranes were immersed in blocking buffer containing Tween 20
(0.2% v/v) and 1 mg/ml anti-sheep IgG conjugated to IR dye 680 (Mo-
lecular Probes) and shaken for 1 hr, protected from light. The mem-
branes were then washed six times for 5 min using TBST and once
for 5 min in PBS. The membranes were scanned in the 700 nm channel
using the Odyssey IR imager, and LKB1 protein levels were quantified
using Odyssey IR imaging system software.
Statistical Analyses
All data are reported as means ± SEM. Results were analyzed using
Student’s t test. Differences were considered statistically significant
at p < 0.05.
Supplemental Data
Supplemental Data include one figure and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/5/2/
151/DC1/.
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